SHANGHAI, March 20, 2026 /PRNewswire/ — D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five abstracts ...
SHANGHAI, March 19, 2026 /PRNewswire/ -- D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five ...
SHANGHAI, March 20, 2026 /PRNewswire/ -- D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five ...
BioLife Solutions, Inc. reported past fourth-quarter 2025 sales of US$24.76 million versus US$20.72 million a year earlier, with full-year 2025 revenue of US$96.21 million and a reduced net loss of ...
Despite living in an age of abundant food options and supplements, certain vitamin and mineral deficiencies remain surprisingly common – and vitamin D is among the most widespread. Research suggests ...
BOTHELL, Wash., Feb. 17, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
D3 Bio, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, announced that the US Food and Drug Administration (FDA) has cleared two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results